Off-label disease-modifying therapies for multiple sclerosis in low- and middle-income countries.

Reyes S, Saylor D, Hooker J, Mateen FJ, Sharma V, Mathew T, Becker J, Figueroa E G, Gadama Y, Giovannoni G